In December of 2025, the FDA approved a once-daily pill version of Wegovy
This medication is designed to be administered as a once-weekly injection, providing convenience and flexibility for users
Semaglutide helps to reduce binge eating episodes and reduces hunger cravings while patients on liraglutide or exenatide experienced more hunger during their weight loss treatments
It can be considered for those with a BMI of 27 kg/m2 or higher if there are additional risk factors like controlled high blood pressure, diabetes, or hyperlipidemia
Semaglutide, a Once-Weekly Human GLP-1 Analog, Does Not Reduce the Bioavailability of the Combined Oral Contraceptive, Ethinylestradiol/Levonorgestrel. Journal of Clinical Pharmacology, 55(5), 497-504